語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
In vivo reprogramming in regenerativ...
~
SpringerLink (Online service)
In vivo reprogramming in regenerative medicine
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
In vivo reprogramming in regenerative medicine/ edited by Acelya Yilmazer.
其他作者:
Yilmazer, Acelya.
出版者:
Cham :Springer International Publishing : : 2017.,
面頁冊數:
xvii, 103 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Regenerative medicine. -
電子資源:
http://dx.doi.org/10.1007/978-3-319-65720-2
ISBN:
9783319657202
In vivo reprogramming in regenerative medicine
In vivo reprogramming in regenerative medicine
[electronic resource] /edited by Acelya Yilmazer. - Cham :Springer International Publishing :2017. - xvii, 103 p. :ill., digital ;24 cm. - Stem cell biology and regenerative medicine,2196-8985. - Stem cell biology and regenerative medicine..
Chapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.
There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic.
ISBN: 9783319657202
Standard No.: 10.1007/978-3-319-65720-2doiSubjects--Topical Terms:
782729
Regenerative medicine.
LC Class. No.: R856
Dewey Class. No.: 610.28
In vivo reprogramming in regenerative medicine
LDR
:02465nam a2200325 a 4500
001
921814
003
DE-He213
005
20180511134159.0
006
m d
007
cr nn 008maaau
008
190624s2017 gw s 0 eng d
020
$a
9783319657202
$q
(electronic bk.)
020
$a
9783319657196
$q
(paper)
024
7
$a
10.1007/978-3-319-65720-2
$2
doi
035
$a
978-3-319-65720-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
R856
072
7
$a
PSF
$2
bicssc
072
7
$a
SCI049000
$2
bisacsh
082
0 4
$a
610.28
$2
23
090
$a
R856
$b
.I35 2017
245
0 0
$a
In vivo reprogramming in regenerative medicine
$h
[electronic resource] /
$c
edited by Acelya Yilmazer.
260
$a
Cham :
$c
2017.
$b
Springer International Publishing :
$b
Imprint: Humana Press,
300
$a
xvii, 103 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Stem cell biology and regenerative medicine,
$x
2196-8985
505
0
$a
Chapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.
520
$a
There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic.
650
0
$a
Regenerative medicine.
$3
782729
650
1 4
$a
Life Sciences.
$3
593888
650
2 4
$a
Regenerative Medicine/Tissue Engineering.
$3
1020916
650
2 4
$a
Stem Cells.
$3
782732
650
2 4
$a
Cell Culture.
$3
783886
650
2 4
$a
Transplant Surgery.
$3
674230
700
1
$a
Yilmazer, Acelya.
$3
1196987
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
830
0
$a
Stem cell biology and regenerative medicine.
$3
885215
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-65720-2
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入